NUWE (Nuwellis Corp) חוב כולל להון
Nuwellis, Inc. (NUWE) minimizes medical risks by developing systems for removing excess fluid in patients with kidney and heart failure. The company's revenue is based on the sale of Aquadex blood ultrafiltration systems. Management is currently focused on internal restructuring, B2B partnerships, and selling software to clinics. The dynamics of the debt-to-equity ratio stand at 0.00, which is clearly demonstrated by the price chart on the GURU.Markets platform.
%20-%20%D7%99%D7%97%D7%A1%20%D7%9B%D7%9C%D7%9C%20%D7%94%D7%97%D7%95%D7%91%D7%95%D7%AA%20%D7%9C%D7%9E%D7%A7%D7%95%D7%A8%D7%95%D7%AA%20%D7%A2%D7%A6%D7%9E%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_NUWE_-_Nuwellis-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "NUWE (CHF Solutions) היסטוריית חוב כולל להון מ-04.07.2022 עד 01.11.2026 | 👁️GURU.Markets👁️")
פילוחים אנליטיים ודוחות נתונים של חברת Nuwellis Corp (NUWE)
The integration of Inertia devices into US intensive care units creates a steady revenue stream from consumables, which determines the ability of Nuwellis, Inc. (NUWE) to service its obligations. The dynamics of the total debt-to-equity ratio reflect the proportion of borrowed funds to net assets, allowing investors to assess financial stability and the risk of capital impairment should credit conditions change.